Who founded Reconnect Labs?

Reconnect Labs was founded by Michael Kometer.

Who are Reconnect Labs's investors?

Reconnect Labs's investors include LIONHEART VENTURES.

Reconnect Labs

1 known investors

Reconnect Labs develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders, drawing on clinical drug development and psychiatric research. It operates in the neuropsychiatry and clinical drug development space.

Biotech Digital Health Healthtech Mental Health

Founders & leadership

Michael KometerinBoard Chairman & Co-founder

Investors · 1

LIONHEART VENTURESSan Francisco

Competitors · 1

by search overlap

Reunion Neuroscience3 shared keywordsReunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder. Its lead candidate, luvesilocin (RE104), is a short-duration prodrug of 4-OH-DiPT that targets the serotonin 2A receptor.

Companies competing with Reconnect Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Reconnect Labs do?: Reconnect Labs develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders, drawing on clinical drug development and psychiatric research. It operates in the neuropsychiatry and clinical drug development space.
Who founded Reconnect Labs?: Reconnect Labs was founded by Michael Kometer.
Who are Reconnect Labs's investors?: Reconnect Labs's investors include LIONHEART VENTURES.